Filing Flows › NeuroPace (NPCE) › Q2 2026 › vs Q1 2026
NeuroPace (NPCE) Q2 2026 vs Q1 2026 (quarter over quarter)
NeuroPace's revenue rose $758K (+3%) from $22.1M in Q1 2026 to $22.8M in Q2 2026.
NeuroPace, Q2 2026: revenue $22.8M (+17% year over year), operating margin -22.5%, net loss $6.2M, operating cash flow −$3.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $22.8M | $22.1M | $758K | +3% |
| Net loss | $6.2M | $6.7M | −$489K | -7% |
| Costs & expenses | $29.0M | $28.8M | $269K | +0.9% |
| Operating costs | $28.0M | $27.6M | $333K | +1% |
| Interest & other, net | $1.1M | $1.1M | −$64K | -6% |
| Cost of revenue | $3.9M | $4.0M | −$100K | -2% |
| Research & development | $6.9M | $7.2M | −$291K | -4% |
| Sales & marketing | $12.1M | $11.6M | $541K | +5% |
| General & admin | $5.0M | $4.8M | $183K | +4% |
| Operating cash sources | $6.3M | $8.2M | −$1.9M | -23% |
| Depreciation | $100K | $60K | $40K | +67% |
| Share-based compensation | $2.3M | $2.3M | $25K | +1% |
| Cash used in operations | $3.9M | $5.9M | −$2.0M | -34% |
| Net loss absorbed | $6.2M | $6.7M | −$489K | -7% |
| Working capital & other | $106K | $1.5M | −$1.4M | -93% |
Questions
How much did NeuroPace's revenue grow quarter over quarter in Q2 2026?
NeuroPace's revenue rose $758K (+3%) from $22.1M in Q1 2026 to $22.8M in Q2 2026.